Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Laurin

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Metabolites|July 2, 2021
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) InhibitorsNoah R Flynn, Michael D Ward, Mary A Schleiff, et al.
Molecular Psychiatry|August 28, 2013
Genome-wide analyses of borderline personality featuresG H Lubke, C Laurin, N Amin, et al.
Journal of Medicinal Chemistry|June 25, 2026
Design of Potent and Selective BCL6 Transcriptional Chemical Inducers of Proximity through Linker OptimizationFang-Chi Chang, Veronika M Shoba, Oleh Shyshlyk, et al.
ACS Infectious Diseases|November 18, 2020
Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of <i>Trypanosoma cruzi</i>Corentine M C Laurin, Joseph P Bluck, Anthony K N Chan, et al.
Bioorganic & Medicinal Chemistry|May 20, 2018
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stabilityLaura E Jennings, Matthias Schiedel, David S Hewings, et al.
Journal of Medicinal Chemistry|July 13, 2021
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP BromodomainMichael Brand, James Clayton, Mustafa Moroglu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Metabolites|July 2, 2021
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) InhibitorsNoah R Flynn, Michael D Ward, Mary A Schleiff, et al.
Molecular Psychiatry|August 28, 2013
Genome-wide analyses of borderline personality featuresG H Lubke, C Laurin, N Amin, et al.
Journal of Medicinal Chemistry|June 25, 2026
Design of Potent and Selective BCL6 Transcriptional Chemical Inducers of Proximity through Linker OptimizationFang-Chi Chang, Veronika M Shoba, Oleh Shyshlyk, et al.
ACS Infectious Diseases|November 18, 2020
Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of <i>Trypanosoma cruzi</i>Corentine M C Laurin, Joseph P Bluck, Anthony K N Chan, et al.
Bioorganic & Medicinal Chemistry|May 20, 2018
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stabilityLaura E Jennings, Matthias Schiedel, David S Hewings, et al.
Journal of Medicinal Chemistry|July 13, 2021
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP BromodomainMichael Brand, James Clayton, Mustafa Moroglu, et al.
Pageof 3